No profile data available.
CVRx, Inc. (CVRX) is a healthcare company in the heart treatment equipment industry, based in Minneapolis, United States, with about 223 full-time employees.
It reported revenue of $56.65 million for fiscal year 2025, up 10.4% from fiscal year 2024, and net income of -$53.31 million. United States was its largest region in fiscal year 2025, with 92% of revenue. Its market capitalization was $42.09 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.
CVRx reported $56.65 million in revenue for fiscal year 2025, up 10.4% from $51.29 million in fiscal year 2024.
United States: 92% of revenue by region in fiscal year 2025, followed by Europe (8%).
$42.09 million as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include Anteris Technologies Global Corp. (AVR), Stereotaxis, Inc. (STXS), Streamex Corp. (STEX), HeartBeam, Inc. (BEAT).